|By Marketwired .||
|July 10, 2014 09:15 AM EDT||
SAN DIEGO, CA -- (Marketwired) -- 07/10/14 -- SpectraScience, Inc. (OTCQB: SCIE), a medical device company utilizing light technologies to detect and diagnose cancers, announced today that its 2014 annual meeting of shareholders will be held at the law offices of Fredrikson & Byron, PA, located at 200 South Sixth Street, Suite 4000, Minneapolis, Minnesota 55402 on Thursday, August 21, 2014 at 9:30 AM Central Time.
The company announced that July 11, 2014, has been fixed as the record date for determination of the shareholders of the company entitled to notice of, and to vote at, the annual meeting.
Also, the company announced that it will hold an investor conference call on Tuesday, August 26, 2014 at 4:30 p.m. Eastern (1:30 p.m. Pacific) to provide an update on its business and conduct a question and answer session for those who were not able to attend the annual meeting. Instructions and a dial-in phone number will be provided in a subsequent news release.
About SpectraScience, Inc.:
SpectraScience is a San Diego based medical device company that designs, develops, manufactures and markets spectrophotometry systems capable of determining whether tissue is normal, pre-cancerous or cancerous without physically removing tissue from the body. The WavSTAT Optical Biopsy System uses light to optically scan tissue and provide the physician with an immediate analysis. With FDA approval for sale in the U.S. and the CE Mark for the European Union, the WavSTAT System is the first commercially available product that incorporates this innovative technology for clinical use.
For more information:
Visit our web site www.spectrascience.com
Forward-Looking Statement for SpectraScience, Inc.
This news release contains forward-looking statements that involve risks and uncertainties that may cause SpectraScience's actual results to differ materially from results discussed in forward-looking statements. Readers are urged to carefully review and consider the various disclosures made by SpectraScience in this news release, its most recent Form 10-K and in SpectraScience's other reports filed with the Securities and Exchange Commission ("SEC") that attempt to advise interested parties of the risks and factors that may affect SpectraScience's business. These forward-looking statements are qualified in their entirety by the cautions and risk factors filed by SpectraScience in its annual report on Form 10-K and other documents.
Media and Investors:
Phone: (858) 847-0200 x2019
Email: Email Contact
Mar. 23, 2017 12:00 AM EDT Reads: 1,105
Mar. 22, 2017 11:00 PM EDT Reads: 2,912
Mar. 22, 2017 10:15 PM EDT Reads: 1,692
Mar. 22, 2017 10:15 PM EDT Reads: 3,182
Mar. 22, 2017 10:15 PM EDT Reads: 3,230
Mar. 22, 2017 09:30 PM EDT Reads: 2,288
Mar. 22, 2017 06:15 PM EDT Reads: 3,924
Mar. 22, 2017 05:45 PM EDT Reads: 1,788
Mar. 22, 2017 04:30 PM EDT Reads: 797
Mar. 22, 2017 03:45 PM EDT Reads: 1,142
Mar. 22, 2017 03:30 PM EDT Reads: 782
Mar. 22, 2017 03:15 PM EDT Reads: 529
Mar. 22, 2017 02:45 PM EDT Reads: 2,218
Mar. 22, 2017 02:15 PM EDT Reads: 2,162
DevOps is often described as a combination of technology and culture. Without both, DevOps isn't complete. However, applying the culture to outdated technology is a recipe for disaster; as response times grow and connections between teams are delayed by technology, the culture will die. A Nutanix Enterprise Cloud has many benefits that provide the needed base for a true DevOps paradigm.
Mar. 22, 2017 02:00 PM EDT Reads: 845